NYSE · Medical - Devices

INSP (INSP) Stock

$50.93 +3.54% NYSE: INSP Healthcare

Valuation

MetricValue
Price$50.93
Market Cap$1.47B
P/E Ratio8.73
P/B Ratio1.57
P/S Ratio1.32
EPS (TTM)$4.89
52-Week High$147.03
52-Week Low$38.91
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE18.57%
ROA15.99%
ROCE6.53%
Gross Margin5.59%
Operating Margin5.59%
Net Margin14.33%
Debt/Equity0.04
Current Ratio6.08

Annual Financials (USD)

Metric20212022202320242025
Revenue$233.0M$408.0M$625.0M$803.0M$912.0M
Operating Profit$-40.0M$-48.0M$-40.0M$36.0M$51.0M
Net Profit$-42.0M$-45.0M$-21.0M$54.0M$145.0M
EPS$-1.54$-1.60$-0.72$1.75$4.89
Op Margin-17.1%-11.7%-6.5%4.5%5.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$295.0M$565.0M$677.0M$808.0M$907.0M
Total Liabilities$66.0M$69.0M$104.0M$119.0M$126.0M
Cash$214.0M$442.0M$186.0M$150.0M$105.0M
Borrowings$34.0M$16.0M$25.0M$32.0M$32.0M

Latest News

Inspire Medical Systems (INSP) Faces A Fresh Test As Recalls Put Valuation In Focus Simply Wall St. · Jul 10, 2026 2 Reasons INSP is Risky and 1 Stock to Buy Instead StockStory · Jul 9, 2026 1 Russell 2000 Stock to Target This Week and 2 Facing Challenges StockStory · Jul 8, 2026 Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026 GlobeNewswire · Jul 6, 2026 Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026 GlobeNewswire · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-20.0M$12.0M$25.0M$130.0M$117.0M
Investing Cash Flow$24.0M$-29.0M$-318.0M$-152.0M$-17.0M
Financing Cash Flow$0$0$-17.0M$-80.0M$-198.0M
Net Cash Flow$24.0M$227.0M$-256.0M$-35.0M$-45.0M
Free Cash Flow$-25.0M$2.0M$1.0M$91.0M$78.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA17.80
FCF Yield8.02%
Quick Ratio4.48
Interest Coverage—
Return 1Y-61.38%
Return 3Y-82.42%
Return 5Y-71.79%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADUS $116.46 +2.46% 17.77 $2.17B 0.00%
AORT $27.12 +2.07% 108.24 $1.32B 0.00%
ARDT $10.73 -1.83% 10.45 $1.54B 0.00%
BKDBrookdale Senior Living Inc. $15.55 +2.61% -17.64 $3.71B 0.00%
ETNB89bio, Inc. $14.84 +0.00% -12.82 $2.20B 0.00%

About INSP

INSP is led by CEO Timothy Herbert, publicly traded since 2018.

INSP stock trades at $50.93 with a market capitalization of $1.47B. The stock is valued at a price-to-earnings (P/E) ratio of 8.73, price-to-book of 1.57, price-to-sales of 1.32. Over the past 52 weeks the stock has ranged between $38.91 and $147.03, and currently trades 65.4% below its 52-week high.

On profitability, INSP generates a return on equity (ROE) of 18.57%, above the typical market average, return on capital employed of 6.53%, an operating margin of 5.59%, a net profit margin of 14.33%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides